Ranitidine pharmacokinetics in newborn infants. 1993

M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
Fourth Department of Paediatrics, University of Milan Medical School, Italy.

Few data are available for ranitidine pharmacokinetics in the first few days of life. Twenty seven newborn infants were treated with intravenous ranitidine because they were vomiting blood, although they had a negative Apt's test. Each infant provided two blood samples at randomly selected times 30-360 minutes after a 2.4 mg/kg intravenous bolus of ranitidine. A single exponential equation for the concentration-time graph was fitted to the mean serum concentrations at different times. From this model the following mean (SD) measurements wer derived: elimination half life, 207.1 (19.1) minutes; total volume of distribution, 1.52 (0.91) l/kg; and total plasma clearance, 5.02 (0.46) ml/kg/min. Assuming that these measurements do not change with different administered doses, regimens can be derived to assist in planning ranitidine treatment in newborn infants.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
January 1989, Developmental pharmacology and therapeutics,
M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
February 1983, Antimicrobial agents and chemotherapy,
M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
August 1978, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
April 1982, Antimicrobial agents and chemotherapy,
M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
January 1993, Medicina,
M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
October 1984, Antimicrobial agents and chemotherapy,
M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
January 1984, Pediatric pharmacology (New York, N.Y.),
M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
January 1986, Pediatric pharmacology (New York, N.Y.),
M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
February 1987, The Journal of pediatrics,
M Fontana, and E Massironi, and A Rossi, and P Vaglia, and G P Gancia, and P Tagliabue, and N Principi
May 1984, The Journal of pediatrics,
Copied contents to your clipboard!